scholarly article | Q13442814 |
review article | Q7318358 |
P356 | DOI | 10.1007/BF02017703 |
P698 | PubMed publication ID | 3536500 |
P2093 | author name string | G L Ridgway | |
P2860 | cites work | Single dose ciprofloxacin for treating gonococcal infections in men. | Q33582910 |
Evaluation of ciprofloxacin 500 mg twice daily for one week in treating uncomplicated gonococcal chlamydial, and non-specific urethritis in men. | Q33583148 | ||
In vitro activity of clavulanic acid, amoxicillin, and ticarcillin against Chlamydia trachomatis | Q35650054 | ||
Comparative in vitro activity of RU 28965 against Chlamydia trachomatis | Q37902524 | ||
In-vitro and in-vivo activity of parenterally administered beta-lactam antibiotics against Chlamydia trachomatis | Q37903163 | ||
Partial efficacy of clindamycin against Chlamydia trachomatis in men with nongonococcal urethritis | Q37903166 | ||
Unsuccessful treatment of non-gonococcal urethritis with rosoxacin provides information on the aetiology of the disease | Q37904698 | ||
Activity of the newer quinolones against Chlamydia trachomatis | Q37905259 | ||
The activity of ciprofloxacin and other 4-quinolones againstChlamydia trachomatis andMycoplasmas in vitro | Q37905501 | ||
Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis | Q37906518 | ||
In vitro activity of rifamycins alone and in combination with other antibiotics against Chlamydia trachomatis. | Q37906901 | ||
Rosaramicin and tetracycline in the treatment of non-gonococcal urethritis. A comparison of clinical and microbiological results. | Q37908189 | ||
Treatment of nongonococcal urethritis with rifampicin as a means of defining the role of Ureaplasma urealyticum | Q37910896 | ||
The antimicrobial susceptibility of Chlamydia trachomatis in cell culture | Q37911356 | ||
A method for testing the antibiotic susceptibility of Chlamydia trachomatis in a cell culture system | Q37912200 | ||
In Vitro Susceptibility of Ureaplasma urealyticum to Rosaramicin | Q40620739 | ||
In vitro activity of amifloxacin against Chlamydia trachomatis and Ureaplasma urealyticum | Q43440685 | ||
Antichlamydial activity of quinolone carboxylic acids | Q43441012 | ||
In vitro activity of ciprofloxacin against clinical isolates of Chlamydia trachomatis | Q43441418 | ||
In vitro activity of norfloxacin againstChlamydia trachomatis | Q43442073 | ||
A new Micromonospora-produced macrolide antibiotic, rosamicin | Q54655337 | ||
P433 | issue | 5 | |
P921 | main subject | chemotherapy | Q974135 |
P304 | page(s) | 550-553 | |
P577 | publication date | 1986-10-01 | |
P1433 | published in | European journal of clinical microbiology | Q27710821 |
P1476 | title | Antimicrobial chemotherapy of chlamydial infection: where next? | |
P478 | volume | 5 |
Q37894802 | Azithromycin vs doxycycline in the treatment of non-gonococcal urethritis |
Q38657865 | Clinical pharmacokinetic properties of the macrolide antibiotics. Effects of age and various pathophysiological states (Part II). |
Q28359405 | In vitro and in vivo antibacterial activities of BMY 40062, a new fluoronaphthyridone |
Q36711581 | Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use. |
Q39658490 | Ofloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. |
Q34674654 | Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. |
Q35563856 | Rapid determination of MICs of 15 antichlamydial agents by using an enzyme immunoassay (Chlamydiazyme). |
Q37900922 | Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms |
Search more.